Literature DB >> 8357933

Production of cytolethal distending toxin (CLDT) by Campylobacter fetus subsp. fetus isolated from calves.

T Ohya1, K Tominaga, M Nakazawa.   

Abstract

Cytolethal distending toxin (CLDT) production by Campylobacter fetus subsp. fetus isolated from calves was examined using CHO cells. Twenty-five of the 26 strains tested were positive for CLDT with titer of ranging 1:8 to 1:2,048. CLDT positive strains were divided into low and high cytotoxin titer groups. Isolates from diarrhea cases tended to produce a significant amount of CLDT compared with isolates from liver. CLDT produced by C. fetus showed no effect on Y-1 cells and was heat-labile and trypsin-sensitive.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8357933     DOI： 10.1292/jvms.55.507

Source DB:  PubMed          Journal:  J Vet Med Sci        ISSN： 0916-7250            Impact factor:   1.267


  9 in total

1.  Toxin production by Campylobacter spp.

Authors:  T M Wassenaar
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

2.  Cholesterol depletion reduces entry of Campylobacter jejuni cytolethal distending toxin and attenuates intoxication of host cells.

Authors:  Chia-Der Lin; Cheng-Kuo Lai; Yu-Hsin Lin; Jer-Tsong Hsieh; Yu-Ting Sing; Yun-Chieh Chang; Kai-Chuan Chen; Wen-Ching Wang; Hong-Lin Su; Chih-Ho Lai
Journal:  Infect Immun       Date:  2011-07-05       Impact factor: 3.441

Review 3.  Cytolethal distending toxin: a conserved bacterial genotoxin that blocks cell cycle progression, leading to apoptosis of a broad range of mammalian cell lineages.

Authors:  Rasika N Jinadasa; Stephen E Bloom; Robert S Weiss; Gerald E Duhamel
Journal:  Microbiology (Reading)       Date:  2011-05-12       Impact factor: 2.777

4.  Escherichia coli CdtB mediates cytolethal distending toxin cell cycle arrest.

Authors:  C Elwell; K Chao; K Patel; L Dreyfus
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

5.  Characterization of a Haemophilus ducreyi mutant deficient in expression of cytolethal distending toxin.

Authors:  M K Stevens; J L Latimer; S R Lumbley; C K Ward; L D Cope; T Lagergard; E J Hansen
Journal:  Infect Immun       Date:  1999-08       Impact factor: 3.441

Review 6.  The clinical importance of emerging Campylobacter species.

Authors:  Si Ming Man
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-10-25       Impact factor: 46.802

7.  Escherichia coli cytolethal distending toxin blocks the HeLa cell cycle at the G2/M transition by preventing cdc2 protein kinase dephosphorylation and activation.

Authors:  C Comayras; C Tasca; S Y Pérès; B Ducommun; E Oswald; J De Rycke
Journal:  Infect Immun       Date:  1997-12       Impact factor: 3.441

Review 8.  The Cytolethal Distending Toxin Contributes to Microbial Virulence and Disease Pathogenesis by Acting As a Tri-Perditious Toxin.

Authors:  Monika D Scuron; Kathleen Boesze-Battaglia; Mensur Dlakić; Bruce J Shenker
Journal:  Front Cell Infect Microbiol       Date:  2016-12-05       Impact factor: 5.293

9.  Campylobacter upsaliensis isolated from dogs produces high titer of cytolethal distending toxin.

Authors:  Srinuan Somroop; Noritoshi Hatanaka; Sharda Prasad Awasthi; Kentaro Okuno; Masahiro Asakura; Atsushi Hinenoya; Shinji Yamasaki
Journal:  J Vet Med Sci       Date:  2017-02-16       Impact factor: 1.267
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.